Regenerative medicine and stem cell therapy emerge for CKD treatment

Current treatments for chronic kidney disease (CKD) primarily focus on managing symptoms, slowing disease progression, and addressing co-morbidities such as diabetes and hypertension. Standard care includes lifestyle modifications, dietary interventions, and medications like SGLT2 inhibitors, ACE inhibitors, and diuretics. For end-stage renal disease, dialysis and kidney transplantation remain the primary options.

There is an emerging shift toward regenerative medicine to address the gap in repairing damaged kidney tissue. Researchers are exploring stem cell therapy as a potential method to rejuvenate tissue, modulate immune responses, and address underlying inflammation. Unlike conventional methods that focus on preserving or replacing function, these regenerative approaches aim to restore renal function by repairing the organ itself.